Strattera and Libido decreased - a phase IV clinical study of FDA data

Summary:

Libido decreased is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Xanax, and have Narcolepsy.

The phase IV clinical study analyzes which people have Libido decreased when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Libido decreased?

Libido decreased (loss of interest in sex) is found to be associated with 752 drugs and 912 conditions by eHealthMe. Check the latest studies of Libido decreased.

On Jul, 29, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 81 people (0.3%) have Libido decreased.

Among these 81 people:

How long have people been on Strattera when they have Libido decreased? *

What is the gender of people who have Libido decreased when taking Strattera? *

female: 35 %
male: 65 %

What is the age of people who have Libido decreased when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Libido decreased? *

Erection Problems: 23 people, 28.40%
Fatigue (feeling of tiredness): 21 people, 25.93%
Feeling Abnormal: 17 people, 20.99%
Feeling Jittery: 16 people, 19.75%
Dizziness: 16 people, 19.75%
Agitation (state of anxiety or nervous excitement): 16 people, 19.75%
Drug Ineffective: 16 people, 19.75%
Headache (pain in head): 15 people, 18.52%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 14 people, 17.28%
Insomnia (sleeplessness): 14 people, 17.28%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 14.81%
Drowsiness: 11 people, 13.58%
Stress And Anxiety: 4 people, 4.94%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 3.70%
Insomnia (sleeplessness): 3 people, 3.70%
Bipolar Disorder (mood disorder): 2 people, 2.47%
Disturbance In Attention: 2 people, 2.47%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 1.23%
Dyspnea (difficult or laboured breathing): 1 person, 1.23%
Erection Problems: 1 person, 1.23%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Libido decreased?

- Check whether Libido decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Libido decreased treatments and more:

Libido decreased (16,674 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Libido decreased:

Libido decreased (752 drugs)

Browse all the conditions that are associated with Libido decreased:

Libido decreased (912 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.